Ngā hua rapu - Nils Helge Schebb

Whakamahine hua
  1. 1
    Formation of lipoxins and resolvins in human leukocytes

    Formation of lipoxins and resolvins in human leukocytes mā Astrid S. Kahnt, Nils Helge Schebb, Dieter Steinhilber

    I whakaputaina 2023
    Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  2. 2
    MS-based targeted metabolomics of eicosanoids and other oxylipins: Analytical and inter-individual variabilities

    MS-based targeted metabolomics of eicosanoids and other oxylipins: Analytical and inter-individual variabilities mā Cécile Gladine, Annika I. Ostermann, John W. Newman, Nils Helge Schebb

    I whakaputaina 2019
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  3. 3
    RNAi-based ALOX15B silencing augments keratinocyte inflammation in vitro via EGFR/STAT1/JAK1 signalling

    RNAi-based ALOX15B silencing augments keratinocyte inflammation in vitro via EGFR/STAT1/JAK1 signalling mā Megan A. Palmer, Rebecca Kirchhoff, Claudia Buerger, Yvonne Benatzy, Nils Helge Schebb, Bernhard Brüne

    I whakaputaina 2025
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  4. 4
    Role of soluble epoxide hydrolase phosphatase activity in the metabolism of lysophosphatidic acids

    Role of soluble epoxide hydrolase phosphatase activity in the metabolism of lysophosphatidic acids mā Christophe Morisseau, Nils Helge Schebb, Hua Dong, Arzu Ulu, Pavel A. Aronov, Bruce D. Hammock

    I whakaputaina 2012
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  5. 5
    Investigation of Human Exposure to Triclocarban after Showering and Preliminary Evaluation of Its Biological Effects

    Investigation of Human Exposure to Triclocarban after Showering and Preliminary Evaluation of Its Biological Effects mā Nils Helge Schebb, Bora İnceoğlu, Ki Chang Ahn, Christophe Morisseau, Shirley J. Gee, Bruce D. Hammock

    I whakaputaina 2011
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  6. 6
    Comparison of the effects of long-chain omega-3 fatty acid supplementation on plasma levels of free and esterified oxylipins

    Comparison of the effects of long-chain omega-3 fatty acid supplementation on plasma levels of free and esterified oxylipins mā Nils Helge Schebb, Annika I. Ostermann, Jun Yang, Bruce D. Hammock, Andreas Hahn, Jan Philipp Schuchardt

    I whakaputaina 2014
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  7. 7
    Development of a quantitative proteomics approach for cyclooxygenases and lipoxygenases in parallel to quantitative oxylipin analysis allowing the comprehensive investigation of the arachidonic acid cascade

    Development of a quantitative proteomics approach for cyclooxygenases and lipoxygenases in parallel to quantitative oxylipin analysis allowing the comprehensive investigation of th... mā Nicole M. Hartung, Malwina Mainka, Rebecca Pfaff, Michael Kuhn, Sebastian Biernacki, L. Zinnert, Nils Helge Schebb

    I whakaputaina 2023
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  8. 8
    Modulation of blood oxylipin levels by long-chain omega-3 fatty acid supplementation in hyper- and normolipidemic men

    Modulation of blood oxylipin levels by long-chain omega-3 fatty acid supplementation in hyper- and normolipidemic men mā Jan Philipp Schuchardt, Simone Schmidt, Gaby Kressel, Ina Willenberg, Bruce D. Hammock, Andreas Hahn, Nils Helge Schebb

    I whakaputaina 2014
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  9. 9
    Effects of a 12-week high-α-linolenic acid intervention on EPA and DHA concentrations in red blood cells and plasma oxylipin pattern in subjects with a low EPA and DHA status

    Effects of a 12-week high-α-linolenic acid intervention on EPA and DHA concentrations in red blood cells and plasma oxylipin pattern in subjects with a low EPA and DHA status mā Theresa Greupner, Laura Kutzner, Fabian Nolte, Alena Strangmann, Heike Kohrs, Andreas Hahn, Nils Helge Schebb, Jan Philipp Schuchardt

    I whakaputaina 2018
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  10. 10
    Efferocytosis potentiates the expression of arachidonate 15-lipoxygenase (ALOX15) in alternatively activated human macrophages through LXR activation

    Efferocytosis potentiates the expression of arachidonate 15-lipoxygenase (ALOX15) in alternatively activated human macrophages through LXR activation mā Ryan G. Snodgrass, Yvonne Benatzy, Tobias Schmid, Dmitry Namgaladze, Malwina Mainka, Nils Helge Schebb, Dieter Lütjohann, Bernhard Brüne

    I whakaputaina 2020
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  11. 11
    Comparison of free serum oxylipin concentrations in hyper- vs. normolipidemic men

    Comparison of free serum oxylipin concentrations in hyper- vs. normolipidemic men mā Jan Philipp Schuchardt, Simone Schmidt, Gaby Kressel, Hua Dong, Ina Willenberg, Bruce D. Hammock, Andreas Hahn, Nils Helge Schebb

    I whakaputaina 2013
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  12. 12
    LC-ESI-HRMS — lipidomics of phospholipids

    LC-ESI-HRMS — lipidomics of phospholipids mā Katharina M. Rund, Laura Carpanedo, Robin Lauterbach, Tim Wermund, Annette L. West, L. Wende, Philip C. Calder, Nils Helge Schebb

    I whakaputaina 2024
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  13. 13
    Acute augmentation of epoxygenated fatty acid levels rapidly reduces pain-related behavior in a rat model of type I diabetes

    Acute augmentation of epoxygenated fatty acid levels rapidly reduces pain-related behavior in a rat model of type I diabetes mā Bora İnceoğlu, Karen Wagner, Jun Yang, Ahmed Bettaieb, Nils Helge Schebb, Sung Hee Hwang, Christophe Morisseau, Fawaz G. Haj, Bruce D. Hammock

    I whakaputaina 2012
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  14. 14
    Effects of chronic low‐dose aspirin treatment on tumor prevention in three mouse models of intestinal tumorigenesis

    Effects of chronic low‐dose aspirin treatment on tumor prevention in three mouse models of intestinal tumorigenesis mā Nadine Rohwer, Anja A. Kühl, Annika I. Ostermann, Nicole M. Hartung, Nils Helge Schebb, Dieter Zopf, Fiona McDonald, Karsten H. Weylandt

    I whakaputaina 2020
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  15. 15
    Long-term stimulation of toll-like receptor-2 and -4 upregulates 5-LO and 15-LO-2 expression thereby inducing a lipid mediator shift in human monocyte-derived macrophages

    Long-term stimulation of toll-like receptor-2 and -4 upregulates 5-LO and 15-LO-2 expression thereby inducing a lipid mediator shift in human monocyte-derived macrophages mā Roland Ebert, Rivelino Cumbana, Christoph Lehmann, Laura Kutzner, Andy Toewe, Nerea Ferreirós, Michael J. Parnham, Nils Helge Schebb, Dieter Steinhilber, Astrid S. Kahnt

    I whakaputaina 2020
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  16. 16
    Plasma oxylipins respond in a linear dose-response manner with increased intake of EPA and DHA: results from a randomized controlled trial in healthy humans

    Plasma oxylipins respond in a linear dose-response manner with increased intake of EPA and DHA: results from a randomized controlled trial in healthy humans mā Annika I. Ostermann, Annette L. West, Kirsten Schoenfeld, Lucy M. Browning, Celia G. Walker, Susan A. Jebb, Philip C. Calder, Nils Helge Schebb

    I whakaputaina 2019
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  17. 17
    ALOX15B controls macrophage cholesterol homeostasis via lipid peroxidation, ERK1/2 and SREBP2

    ALOX15B controls macrophage cholesterol homeostasis via lipid peroxidation, ERK1/2 and SREBP2 mā Yvonne Benatzy, Megan A. Palmer, Dieter Lütjohann, Rei-ichi Ohno, Nadja Kampschulte, Nils Helge Schebb, Dominik C. Fuhrmann, Ryan G. Snodgrass, Bernhard Brüne

    I whakaputaina 2024
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  18. 18
    Oral treatment of rodents with soluble epoxide hydrolase inhibitor 1-(1-propanoylpiperidin-4-yl)-3-[4-(trifluoromethoxy)phenyl]urea (TPPU): Resulting drug levels and modulation of oxylipin pattern

    Oral treatment of rodents with soluble epoxide hydrolase inhibitor 1-(1-propanoylpiperidin-4-yl)-3-[4-(trifluoromethoxy)phenyl]urea (TPPU): Resulting drug levels and modulation of... mā Annika I. Ostermann, Jan Herbers, Ina Willenberg, Rongjun Chen, Sung Hee Hwang, Robert Greite, Christophe Morisseau, Faikah Gueler, Bruce D. Hammock, Nils Helge Schebb

    I whakaputaina 2015
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  19. 19
    Development of an LC-ESI(-)-MS/MS method for the simultaneous quantification of 35 isoprostanes and isofurans derived from the major n3- and n6-PUFAs

    Development of an LC-ESI(-)-MS/MS method for the simultaneous quantification of 35 isoprostanes and isofurans derived from the major n3- and n6-PUFAs mā Katharina M. Rund, Annika I. Ostermann, Laura Kutzner, Jean‐Marie Galano, Camille Oger, Claire Vigor, Sabine Wecklein, Nina Seiwert, Thierry Durand, Nils Helge Schebb

    I whakaputaina 2017
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  20. 20
    Analgesia mediated by soluble epoxide hydrolase inhibitors is dependent on cAMP

    Analgesia mediated by soluble epoxide hydrolase inhibitors is dependent on cAMP mā Bora İnceoğlu, Karen Wagner, Nils Helge Schebb, Christophe Morisseau, Steven L. Jinks, Arzu Ulu, Christine Hegedus, Tristan E. Rose, Robert J. Brosnan, Bruce D. Hammock

    I whakaputaina 2011
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:

Ngā utauta rapu: